pharmacycanada-rxedtop

FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

ARDS program well-positioned for an expedited path to commercialization with RMAT and Fast Track designation Athersys,…